USD 0.23
(-5.78%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 208.76 Thousand USD | 380.05% |
2018 | 43.48 Thousand USD | -92.62% |
2017 | 589.46 Thousand USD | -3.63% |
2016 | 611.68 Thousand USD | 327.26% |
2015 | 143.16 Thousand USD | 139.51% |
2014 | 59.77 Thousand USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | -100.0% |
2023 Q1 | - USD | 0.0% |
2023 Q4 | 42 Thousand USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q1 | - USD | 100.0% |
2020 Q4 | -2271.00 USD | 0.0% |
2020 Q2 | 97.00 USD | -95.54% |
2020 Q1 | 2174.00 USD | -96.83% |
2020 Q3 | - USD | -100.0% |
2020 FY | - USD | -100.0% |
2019 Q4 | 68.5 Thousand USD | 1540.89% |
2019 Q2 | 110.51 Thousand USD | 332.35% |
2019 Q3 | 4175.00 USD | -96.22% |
2019 Q1 | 25.56 Thousand USD | 0.0% |
2019 FY | 208.76 Thousand USD | 380.05% |
2018 Q3 | - USD | -100.0% |
2018 FY | 43.48 Thousand USD | -92.62% |
2018 Q4 | - USD | 0.0% |
2018 Q2 | 15.27 Thousand USD | -45.84% |
2018 Q1 | 28.2 Thousand USD | -93.91% |
2017 FY | 589.46 Thousand USD | -3.63% |
2017 Q4 | 463.58 Thousand USD | 2118.09% |
2017 Q1 | 96.23 Thousand USD | -25.69% |
2017 Q2 | 8744.00 USD | -90.91% |
2017 Q3 | 20.9 Thousand USD | 139.02% |
2016 Q1 | 89.14 Thousand USD | 0.0% |
2016 Q2 | 381.73 Thousand USD | 328.2% |
2016 FY | 611.68 Thousand USD | 327.26% |
2016 Q4 | 129.51 Thousand USD | 1046.23% |
2016 Q3 | 11.29 Thousand USD | -97.04% |
2015 Q1 | 75.82 Thousand USD | 133.55% |
2015 Q3 | - USD | -100.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | 67.34 Thousand USD | -11.19% |
2015 FY | 143.16 Thousand USD | 139.51% |
2014 Q4 | 32.46 Thousand USD | 18.88% |
2014 Q3 | 27.3 Thousand USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | 59.77 Thousand USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Akoya Biosciences, Inc. | 96.63 Million USD | 100.0% |
AngioDynamics, Inc. | 303.91 Million USD | 100.0% |
AtriCure, Inc. | 399.24 Million USD | 100.0% |
Avinger, Inc. | 7.65 Million USD | 100.0% |
Azenta, Inc. | 665.07 Million USD | 100.0% |
BioLife Solutions, Inc. | 143.27 Million USD | 100.0% |
The Cooper Companies, Inc. | 3.59 Billion USD | 100.0% |
Daxor Corporation | 1.28 Million USD | 100.0% |
Ekso Bionics Holdings, Inc. | 18.27 Million USD | 100.0% |
Femasys Inc. | 1.07 Million USD | 100.0% |
Harvard Bioscience, Inc. | 112.25 Million USD | 100.0% |
Hologic, Inc. | 4.03 Billion USD | 100.0% |
ICU Medical, Inc. | 2.25 Billion USD | 100.0% |
Intuitive Surgical, Inc. | 7.12 Billion USD | 100.0% |
KORU Medical Systems, Inc. | 28.51 Million USD | 100.0% |
LeMaitre Vascular, Inc. | 193.48 Million USD | 100.0% |
Innovative Eyewear, Inc. | 1.15 Million USD | 100.0% |
Innovative Eyewear, Inc. | 1.15 Million USD | 100.0% |
Masimo Corporation | 2.04 Billion USD | 100.0% |
Microbot Medical Inc. | - USD | NaN% |
Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 100.0% |
Merit Medical Systems, Inc. | 1.25 Billion USD | 100.0% |
Nephros, Inc. | 14.23 Million USD | 100.0% |
NovoCure Limited | 509.33 Million USD | 100.0% |
NEXGEL, Inc. | 4.08 Million USD | 100.0% |
NEXGEL, Inc. | 4.08 Million USD | 100.0% |
Singular Genomics Systems, Inc. | 2.91 Million USD | 100.0% |
OraSure Technologies, Inc. | 405.47 Million USD | 100.0% |
Pro-Dex, Inc. | 53.84 Million USD | 100.0% |
Pulse Biosciences, Inc. | - USD | NaN% |
Predictive Oncology Inc. | 1.78 Million USD | 100.0% |
Precision Optics Corporation, Inc. | 19.1 Million USD | 100.0% |
QuidelOrtho Corporation | 2.99 Billion USD | 100.0% |
Repligen Corporation | 638.76 Million USD | 100.0% |
Sanara MedTech Inc. | 64.98 Million USD | 100.0% |
STAAR Surgical Company | 322.41 Million USD | 100.0% |
Sharps Technology, Inc. | - USD | NaN% |
Utah Medical Products, Inc. | 50.22 Million USD | 100.0% |
DENTSPLY SIRONA Inc. | 3.96 Billion USD | 100.0% |
Jin Medical International Ltd. | 19.82 Million USD | 100.0% |